BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ex-ArthroCare Corporation (ARTC) Exec Pleads Guilty to $400 Million Stock Fraud Scheme


5/13/2013 9:03:21 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

David Applegate, the former senior vice president for ArthroCare's spinal business, pleads guilty to federal charges that he helped run a $400 million scheme to defraud investors. Ex-ArthroCare (NSDQ:ARTC) executive David Applegate pleaded guilty this week to federal charges that he helped run a scheme that eventually defrauded investors in the medical device company of some $400 million. Applegate, 54, pleaded to 1 count of conspiracy to commit securities, mail & wire fraud and another count of making false statements, for regulatory filings made with the SEC containing faked quarterly and annual sales figures. Applegate and another ex-ArthroCare exec, John Raffle, were arrested last summer and charged by the U.S. Justice Dept. with wire fraud and making false statements in connection with the alleged scheme to artificially inflate ArthroCare's share price by rigging its sales figures, according to court documents.

Help employers find you! Check out all the jobs and post your resume.


Read at MassDevice

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES